BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36789760)

  • 1. Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE).
    Sung S; Hong Y; Kim BG; Choi JY; Kim JW; Park SY; Kim JH; Kim YM; Lee JM; Kim TJ; Park SK
    Cancer Med; 2023 Apr; 12(7):8742-8753. PubMed ID: 36789760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
    Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
    Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
    Modugno F; Ness RB; Wheeler JE
    Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
    Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
    Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
    Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.
    Licaj I; Jacobsen BK; Selmer RM; Maskarinec G; Weiderpass E; Gram IT
    Br J Cancer; 2017 Jan; 116(2):270-276. PubMed ID: 27959888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
    Kelemen LE; Bandera EV; Terry KL; Rossing MA; Brinton LA; Doherty JA; Ness RB; Kjaer SK; Chang-Claude J; Köbel M; Lurie G; Thompson PJ; Carney ME; Moysich K; Edwards R; Bunker C; Jensen A; Høgdall E; Cramer DW; Vitonis AF; Olson SH; King M; Chandran U; Lissowska J; Garcia-Closas M; Yang H; Webb PM; Schildkraut JM; Goodman MT; Risch HA; ;
    BMC Cancer; 2013 Jan; 13():28. PubMed ID: 23339562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
    Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
    Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of smoking, alcohol, and coffee consumption with the risk of ovarian cancer and prognosis: a mendelian randomization study.
    Liu S; Feng S; Du F; Zhang K; Shen Y
    BMC Cancer; 2023 Mar; 23(1):256. PubMed ID: 36941558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
    Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
    Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    Gupta M; Babic A; Beck AH; Terry K
    Hum Pathol; 2016 Aug; 54():82-91. PubMed ID: 27068525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol consumption and ovarian cancer risk in a population-based case-control study.
    Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Hampton JM; Willett WC; Egan KM
    Int J Cancer; 2006 Nov; 119(10):2423-7. PubMed ID: 16921486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study.
    Toufakis V; Katuwal S; Pukkala E; Tapanainen JS
    Acta Oncol; 2021 Jul; 60(7):850-855. PubMed ID: 33999765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
    Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
    J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
    Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
    Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
    Rice MS; Hankinson SE; Tworoger SS
    Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
    Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
    Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
    Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
    Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.